In 2003, Menkiszak et al. observed that 13.5% of ovarian cancer patients in the West Pomerania region carry one of these three common founder mutations in BRCA1 (c.5266dupC, c.181T > G, and c.4035delA) gene [8]. This evidence concerns the gene BRCA1 and ovarian carcinoma.